microdosing glp 1 tirzepatide Women's & Weight Maintenance Microdosing GLP-1: A New Approach
Description
Conclusions: GLP-1 agonist use in patients with type 1 diabetes may be advantageous where weight reduction becomes both a constraint and a therapeutic objective
"It goes back to changing that behavior, not relying just on a medication to help you keep that weight down
WH, RS, RC, CL, RG, WT, JZ and QZ drafted and revised the manuscript
A healthcare provider may increase the dose depending on someones response to the medication
Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S, Starup-Linde J
doi: 10.1016/j.jsps.2023.101923 52 ZhaoWZhangXZhouZSunBGuWLiuJet al
